Humatics Secures $30M in Series B Funding

Humatics has secured $30 million in Series B funding to scale its sub-millimeter Milo Microlocation System and increase its footprint in the transit industry with its proprietary Rail Navigation System, among other investments, company leadership announced today.

Blackhorn Ventures led the funding round, with Tenfore Holdings, Fontinalis Partners, Airbus Ventures, Lockheed Martin Ventures, and Presidio Ventures following suit. The $30 million infusion grows the company’s funding by a third, bringing its total raised to over $80 million.

David Mindell, CEO Humatics

“This visionary $30 million investment will help bring Humatics microlocation technology to scale across the globe” said David Mindell, CEO of Humatics. “Microlocation technology is useful especially now, as we try to keep each other safe by providing space and keeping people and goods moving. We are grateful to Blackhorn and our other investors for sharing that vision.”

“We’re excited to lead the Series B round and invest in the Humatics team,” said Trevor Zimmerman, managing partner of Blackhorn Ventures. “Humatics’ focus on developing location and navigation technology for the transit space and millimeter scale precise positioning technology for manufacturing, logistics, construction and medical unlocks unprecedented collaboration between humans, machines and infrastructure. We look forward to working with the Humatics team to leverage the tremendous success they’ve had with their Rail Navigation System and Microlocation System.”

Humatics proprietary Milo Microlocation System has broad uses across the manufacturing, logistics, industrial equipment, healthcare and construction spaces, helping to identify with millimeter precision where objects are in relation to each other, facilitating seamless collaboration between people, machines, robots and infrastructure. In manufacturing, the technology improves the speed and accuracy of autonomous lineside delivery, making it possible for lineside workers to take on other high-value tasks, and to facilitate tool endpoint tracking for faster, and better-quality assembly procedures. For other markets such as healthcare, construction, and security, Humatics envisions this technology fundamentally transforming how we conduct surgeries, manage secure spaces and utilize construction tools to make sure everything goes according to plan.

Humatics uses UWB, IMU and offers integration with additional sensors for additional safety, and robustness.

In transportation, Humatics Rail Navigation System improves transit vehicle navigation and positioning which helps trains run closer together, speeding up throughput and improving safety in some of the nation’s busiest urban environments. These upgrades are proving critical as transit systems recover from Covid-19 slowdowns.

Humatics recently completed a successful pilot project to install its ultra-wideband technology on 5.5 miles of track in New York City’s subway system. The pilot showcased the technology’s durability, ease of installation, and potential to speed train throughput in one of the busiest transportation networks on the globe. For more information on Humatics’ work on the MTA UWB Pilot, see here.

The company also aims to expand its transportation footprint beyond New York City– helping large- and mid-market transportation systems across the United States and globally upgrade their signaling systems for quicker throughput, improved environmental durability, and reduced maintenance times.

Why it matters: Humatics Round B funding drew in investors well known within the aerospace industry including Airbus Ventures and Lockheed Martin Ventures. The technology, while being demonstrated in rail technology, offers opportunities to provide incredible opportunities within the aerial mobility space. With Humatics micro-location system, eVTOL vehicles will be able to operate in greater densities and navigate around surrounding hazards. Look for companies like Humatics to be at the center of the aerial mobility navigation conversation.